Azithromycin in Chronic Fatigue Syndrome (CFS), an analysis of clinical data
2006

Azithromycin for Chronic Fatigue Syndrome

Sample size: 99 publication Evidence: moderate

Author Information

Author(s): Ruud CW Vermeulen, Hans R Scholte

Primary Institution: CFS and Pain Research Center Amsterdam

Hypothesis

Can azithromycin improve symptoms in patients with Chronic Fatigue Syndrome?

Conclusion

Azithromycin may help reduce symptoms in some Chronic Fatigue Syndrome patients, particularly those with lower acetylcarnitine levels.

Supporting Evidence

  • 59% of patients reported symptom improvement after azithromycin treatment.
  • Responders had lower plasma acetylcarnitine levels compared to non-responders.
  • No patients reported worsening symptoms after treatment.

Takeaway

Some people with Chronic Fatigue Syndrome felt better after taking azithromycin, an antibiotic, especially if they had low levels of a substance called acetylcarnitine.

Methodology

Retrospective analysis of clinical records of CFS patients treated with azithromycin.

Potential Biases

Potential selection bias due to the retrospective nature of the study.

Limitations

The study is retrospective and lacks a control group.

Participant Demographics

Majority of participants were female (88%).

Statistical Information

P-Value

0.023

Confidence Interval

95% CI 0.8 and 10.5

Statistical Significance

p=0.023

Digital Object Identifier (DOI)

10.1186/1479-5876-4-34

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication